Dr. Reddy's Laboratories
RDY
#2005
Rank
NZ$17.73 B
Marketcap
NZ$21.30
Share price
0.00%
Change (1 day)
-16.09%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2026 (TTM): NZ$1.12 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are NZ$3.76 Billion. In 2025 the company made an earning of NZ$1.52 Billion a decrease over its 2024 earnings that were of NZ$1.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.12 B-26.18%
2025 NZ$1.52 B-2.73%
2024 NZ$1.56 B7.01%
2023 NZ$1.46 B32.93%
2022 NZ$1.10 B26.77%
2021 NZ$0.86 B31.44%
2020 NZ$0.66 B54.54%
2019 NZ$0.42 B-14.21%
2018 NZ$0.49 B26.41%
2017 NZ$0.39 B4.47%
2016 NZ$0.37 B-55.7%
2015 NZ$0.85 B1.83%
2014 NZ$0.83 B-3.78%
2013 NZ$0.87 B54.07%
2012 NZ$0.56 B-16.23%
2011 NZ$0.67 B56.66%
2010 NZ$0.43 B-235.36%
2009 -NZ$0.32 Billion-198.53%
2008 NZ$0.32 B30.77%
2007 NZ$0.24 B-14.61%
2006 NZ$0.28 B703.63%
2005 NZ$35.98 M649.45%
2004 NZ$4.8 M-95.68%
2003 NZ$0.11 B-14.86%
2002 NZ$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.57 B 2,278.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.50 B 1,495.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.37 B 1,053.88%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
NZ$17.48 B 1,408.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$3.96 B 242.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel